Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company

By the end of the year, over 180,000 individuals are expected to take part in phase 3 clinical trials for vaccinations against coronavirus. Of the six trials listed, four have acquired U.S. taxpayer funding through the Biomedical Advanced Research and Development Authority (BARDA) or "U.S. Project Warp Speed". This statistic shows the number of expected phase 3 participants and BARDA/Warp Speed funding status of selected COVID-19 vaccines, by company, as of July 28, 2020.

Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

July 2020

Region

Worldwide

Survey time period

as of July 2020

Supplementary notes

* Dose order rather than development funding.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.